Jan. 6, 2020 Price forecast | 2 weeks: -3.60% | 1 month: -7.27% | 3 months: -5.73%


CFX stock forecast

Our latest prediction for Colfax Corp.'s stock price was made on the Jan. 6, 2020 when the stock price was at 37.10$.

In the short term (2weeks), CFX's stock price should underperform the market by -3.60%. During that period the price should oscillate between -5.83% and +3.31%.

In the medium term (3months), CFX's stock price should underperform the market by -5.73%. During that period the price should oscillate between -16.97% and +9.91%.

Create a solid portfolio with CFX

Add CFX to your portfolio and optimize it!


About Colfax Corp.

Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.

At the moment the company generates 3460M USD in revenues.

On its last earning announcement, the company reported a loss of -3.47$ per share.

The book value per share is 27.89$

Colfax Corp. website


Three months stock forecastJan. 6, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
3460M 43.00% 313M 9.00% -471M -3.47 - - 139M 27.89 259M -132M 127M